Zeina Abdel-Rauf, Nakar Helit, Reindorp D Nadir, Nachtigal Alicia, Krausz Michael M, Itamar Itamar, Shapira-Rootman Mika
Department of Radiology, Hillel Yaffe Medical Center, Hadera, Israel, affiliated with the Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.
Division of Surgery, Hillel Yaffe Medical Center, Hadera, Israel, affiliated with the Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.
Isr Med Assoc J. 2017 Apr;19(4):216-220.
Four-dimensional parathyroid computed tomography (4DCT) is a relatively new parathyroid imaging technique that provides functional and highly detailed anatomic information about parathyroid tumors.
To assess the accuracy of 4DCT for the preoperative localization of parathyroid adenomas (PTAs) in patients with biochemically confirmed primary hyperparathyroidism (PHPT) and a history of failed surgery or unsuccessful localization using 99mTc-sestamibi scanning and ultrasonography.
Between January 2013 and January 2015, 55 patients with PHPT underwent 4DCT at Hillel Yaffe Medical Center, Hadera, Israel. An initial unenhanced scan was followed by an IV contrast injection of nonionic contrast material (120 ml of at 4 ml/s). Scanning was repeated 25, 60, and 90 seconds after the initiation of IV contrast administration. An experienced radiologist blinded to the earlier imaging results reviewed the 4DCT for the presence and location (quadrant) of the suspected PTAs. At the time of the study, 28 patients had undergone surgical exploration following 4DCT and we compared their scans with the surgical findings.
4DCT accurately localized 96% (27/28) of abnormal glands, all of which were hypervascular and showed characteristic rapid enhancement on 4DCT that could be distinguished from Level II lymph nodes. Surgery found hypovascular cystic PTA in one patient who produced a negative 4DCT scan. All patients had solitary PTAs. The scan at 90 seconds provided no additional information and was abandoned during the study.
4DCT accurately localized hypervascular parathyroid lesions and distinguished them from other tissues. A three-phase scanning protocol may suffice.
四维甲状旁腺计算机断层扫描(4DCT)是一种相对较新的甲状旁腺成像技术,可提供有关甲状旁腺肿瘤的功能和高度详细的解剖信息。
评估4DCT在生化确诊的原发性甲状旁腺功能亢进症(PHPT)患者中,对甲状旁腺腺瘤(PTA)进行术前定位的准确性,这些患者既往有手术失败史或使用99mTc-甲氧基异丁基异腈扫描及超声检查定位未成功。
2013年1月至2015年1月期间,55例PHPT患者在以色列哈代拉的希勒尔·雅菲医疗中心接受了4DCT检查。首先进行一次平扫,然后静脉注射非离子型对比剂(120 ml,流速4 ml/s)。在静脉注射对比剂开始后25、60和90秒重复扫描。一位对早期成像结果不知情的经验丰富的放射科医生对4DCT进行评估,以确定可疑PTA的存在和位置(象限)。在研究期间,28例患者在4DCT检查后接受了手术探查,我们将他们的扫描结果与手术发现进行了比较。
4DCT准确地定位了96%(27/28)的异常腺体,所有这些腺体均为高血供,在4DCT上显示出特征性的快速强化,可与II级淋巴结区分开来。手术发现1例患者为低血供囊性PTA,其4DCT扫描结果为阴性。所有患者均为单发PTA。90秒时的扫描未提供额外信息,在研究期间被放弃。
4DCT准确地定位了高血供的甲状旁腺病变,并将其与其他组织区分开来。三相扫描方案可能就足够了。